News

Pharmabiz5m
Lupus Foundation of America and Lupus Canada award research grant to study aiming to uncover the causes of fatigue in people with lupus
Lupus Foundation of America and Lupus Canada award research grant to study aiming to uncover the causes of fatigue in people with lupus: Washington, DC Monday, July 28, 2025, 10:0 ...
Pharmabiz2h
Pharmacoeconomics & Real-World Evidence take centrestage in India’s regulatory decision-making
Pharmacoeconomics & Real-World Evidence take centrestage in India’s regulatory decision-making: Nandita Vijayasimha, Bengaluru Monday, July 28, 2025, 08:00 Hrs [IST] India is un ...
Pharmabiz2h
Telangana IDMA warns of closure of small & micro units if revised Schedule M deadline is not extended
Peethaambaran Kunnathoor, Chennai Monday, July 28, 2025, 08:00 Hrs [IST] ...
Pharmabiz1h
CCRAS announces second edition of scientific writing workshop
CCRAS announces second edition of scientific writing workshop: Our Bureau, New Delhi Monday, July 28, 2025, 09:00 Hrs [IST] The Central Council for Research in Ayurvedic Sciences ...
Pharmabiz2h
UP leads way ahead in setting up of Jan Aushadhi Kendras
Uttar Pradesh has moved far ahead in terms of establishing government's low cost, quality generic medicines retail stores Jan Aushadhi Kendras (JAKs) in the State, with more than 20 per cent of the ...
Pharmabiz2h
ICMR invites EoI for commercialization of technology for Leishmania disease testing
ICMR invites EoI for commercialization of technology for Leishmania disease testing: Shardul Nautiyal, Mumbai Monday, July 28, 2025, 08:00 Hrs [IST] The Indian Council of Medical ...
Pharmabiz2h
Regulation on e-pharmacies yet to see the light of day
Gireesh Babu, New Delhi Monday, July 28, 2025, 08:00 Hrs [IST] Despite draft rules for a comprehensive regulation for onlin ...
Pharmabiz1d
Vir Biotech begins patient dosing in phase 1 trial of EGFR-targeting PRO-XTEN dual-masked T-cell engager VIR-5525 to treat solid tumours
Vir Biotech begins patient dosing in phase 1 trial of EGFR-targeting PRO-XTEN dual-masked T-cell engager VIR-5525 to treat solid tumours: San Francisco Saturday, July 26, 2025, 12 ...
Pharmabiz1d
AB Science receives several European countries approval to initiate the confirmatory phase 3 study of masitinib in ALS
AB Science receives several European countries approval to initiate the confirmatory phase 3 study of masitinib in ALS: Paris Saturday, July 26, 2025, 18:00 Hrs [IST] AB Science S ...
Pharmabiz1d
Applied DNA receives new follow-on LineaDNA order from global IVD manufacturer for use in cancer diagnostic application
Applied DNA receives new follow-on LineaDNA order from global IVD manufacturer for use in cancer diagnostic application: Stony Brook, New York Saturday, July 26, 2025, 14:00 Hrs [ ...
Pharmabiz1d
EMA Paediatric Committee elects Sabine Scherer as its new chair
EMA Paediatric Committee elects Sabine Scherer as its new chair: Amsterdam, The Netherlands Saturday, July 26, 2025, 13:30 Hrs [IST] At its July 2025 meeting, EMA’s Paediatric C ...
Pharmabiz1d
Gilead receives positive CHMP opinions under accelerated review from EMA for twice-yearly lenacapavir for HIV prevention
Gilead receives positive CHMP opinions under accelerated review from EMA for twice-yearly lenacapavir for HIV prevention: Foster City, California Saturday, July 26, 2025, 13:00 Hr ...